A new drug has been developed to combat more than 300 resistant bacteria. He noted that the new drug candidate, developed by researchers at ACS Central Science, stopped drug-resistant bacteria in mice with pneumonia and urinary tract infections in laboratory experiments. The researchers underlined that the fabimycin compound in the drug could one day be used to treat difficult infections in humans.
ANTIBIOTIC RESISTANTS
Gram-negative bacteria are a class of microbes that infect millions of people worldwide and cause conditions such as pneumonia, urinary tract infections, and bloodstream infections, according to the U.S. Centers for Disease Control and Prevention (CDC).
These bacteria are known to be particularly difficult to treat and resistant to most antibiotics because they have strong defense systems.
While the scientists who carried out the research reported that the fabimycin compound was effective in the treatment, they emphasized that it could be used in the treatment of microbes that have the ability to mutate to avoid drugs. (Ntv)